CD274 and cancer: A model of the tumor micro-environment based on TILs status (presence/absence) combined with the PD-L1 expression status has been proposed to immunologically categorize different cancers and predict their response to immunotherapy: PD-L1+ TIL+ tumors are most likely to respond to PD-1/PD-L1 blockade therapy [161].